Page 2 - Small Cap Swedish (OMX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Apr 25, 2024

Discover small cap Swedish Pharmaceuticals & Biotech companies that are on the OMX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

124 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ATANA

Attana
kr0.07515.4%-59.5%kr29.1mn/aPS4.3xn/an/a

DIABIO

Diagonal Bio
kr0.075-14.0%-83.0%kr30.1mn/aPS9.6xn/an/a

ELIC

Elicera Therapeutics
kr0.95-20.5%-73.8%kr33.3mn/aPS3xE-10.1%n/a

CHOSA

Chosa Oncology
kr0.530%-59.3%kr34.4mn/aPB2xn/an/a

MODTX

Modus Therapeutics Holding
kr0.97-5.6%-57.9%kr34.8mn/aPB2xE-28.8%n/a

KLAR

Klaria Pharma Holding AB (publ.)
kr0.3334.3%-52.6%kr35.0mkr1.00PB0.9xE29.9%n/a

GABA

Gabather
kr1.9625.6%-56.4%kr35.5mn/aPB73xn/an/a

PROGEN

Prostatype Genomics
kr0.036-17.6%-92.3%kr36.1mn/aPS9.7xn/an/a

RLS

RLS Global
kr0.45-0.2%-84.2%kr35.6mkr7.00PS33.1xE92.8%n/a

LPGO

Lipigon Pharmaceuticals
kr0.33-3.5%-36.6%kr41.3mkr2.50PS2.5xE-35.0%n/a

BIOSGN

Biosergen
kr0.32-21.4%-71.8%kr45.0mkr1.00PB21.3xS41.2%n/a

ONCOZ

OncoZenge
kr3.90-5.2%-57.6%kr45.6mn/aPS15207.7xE99.7%n/a

COEGIN

Coegin Pharma
kr3.024.9%-77.3%kr46.1mn/aPB3.3xn/an/a

NXTCL

NextCell Pharma
kr1.35-48.3%-77.6%kr46.2mn/aPS3xn/an/a

EMPLI

Emplicure
kr0.479.3%-68.5%kr46.5mn/aPB2.2xn/an/a

ALZ

Alzinova
kr1.16-33.3%-54.3%kr51.5mkr12.00PS2.6xE-57.5%n/a

PILA

Pila Pharma
kr2.30-18.7%-17.9%kr54.7mn/aPS37.4xn/an/a

EEVIA

Eevia Health Oyj
kr1.547.7%-39.4%kr55.0mn/aPB1.2xn/an/a

LIPUM

Lipum
kr6.15-8.2%-43.6%kr57.3mkr15.00PB12.5xE-7.4%n/a

SCOL

Scandion Oncology
kr1.45-9.4%-18.1%kr59.0mkr3.20PB1.2xn/an/a

ACUC

AcuCort
kr0.563.7%-63.6%kr60.7mn/aPS9.2xn/an/a

DBP B

Double Bond Pharmaceutical International
kr0.622.7%3.0%kr63.1mn/aPS46xn/an/a

ISAB

Inhalation Sciences Sweden
kr4.340%24.4%kr65.8mkr16.50PS3.8xS59.5%n/a

RESP

Respiratorius
kr0.240%-37.8%kr69.9mn/aPB2.6xS-39.9%n/a
Page 2 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.